← Companies|Caris Life Sciences
Ca

Caris Life Sciences

Irving TXFounded 20082,000 employees
Private CapbiotechPrivateOncology
Platform: Molecular Profile
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
PolatenlimabCAR-7487NDA/BLA1ADCDLL3TROP-2 ADCMigraine
LisocageneCAR-6956Phase 2/32Small MoleculeCFTRWEE1iPV
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)
2025-03-03
Lisocagene Ph3 Readout
PV
Past
2026-05-07
Polatenlimab Ph3 Readout
Migraine
Ph3 Readout
2029-05-10
Lisocagene Ph3 Readout
PV
Ph3 Readout